J05AR01 · Anti-infectives for systemic use
Lamivudine/Zidovudine Teva
Indications
Lamivudine/Zidovudine Teva is indicated in antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (HIV) infection.
Composition
- Active substance
- lamivudine, zidovudine
- International name (INN)
- lamivudine;zidovudine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lamivudine/Zidovudine Teva
- Active substance
- lamivudine, zidovudine
- ATC code
- J05AR01
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- Teva Pharma B.V.